Alveolar Macrophages Prevent Lethal Influenza Pneumonia By Inhibiting Infection Of Type-1 Alveolar Epithelial Cells

PLoS Pathogens

Volumn 13, Issue 1, 2017, Pages

  Cardani, Amber ^a,b   Boulton, Adam ^a   Kim, Taeg S ^a   Braciale, Thomas J ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LEUKOTRIENE D4; CYSTEINE; CYSTEINYL-LEUKOTRIENE; LEUKOTRIENE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CONTROLLED STUDY; FLOW CYTOMETRY; HISTOLOGY; INFLUENZA; LUNG ALVEOLUS EPITHELIUM CELL; LUNG ALVEOLUS MACROPHAGE; LUNG FUNCTION; MOUSE; NONHUMAN; PNEUMONIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; ADAPTIVE IMMUNITY; ANIMAL; BONE MARROW CELL; DISEASE MODEL; GERMFREE ANIMAL; HUMAN; IMMUNOLOGY; INFLUENZA A VIRUS; LUNG; METABOLISM; MUTATION; PATHOLOGY; VIROLOGY; VIRUS PNEUMONIA;

ADAPTIVE IMMUNITY; ALVEOLAR EPITHELIAL CELLS; ANIMALS; CYSTEINE; DISEASE MODELS, ANIMAL; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; LEUKOTRIENES; LUNG; MACROPHAGES, ALVEOLAR; MICE; MUTATION; MYELOID CELLS; PNEUMONIA, VIRAL; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 85010977567     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006140     Document Type: Article

References (52)

1. Thompson WW, Comanor L, Shay DK, Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis. 2006Nov1; 194: S82–S91. doi: 10.1086/50755817163394
2. Hayden F, Croisier A, Transmission of avian influenza viruses to and between humans. J Infect Dis. 2005Oct15; 192 (8): 1311–4. doi: 10.1086/44439916170745
3. Mora R, Rodriguez-Boulan E, Palese P, García-Sastre A, Apical budding of a recombinant influenza A virus expressing a hemagglutinin protein with a basolateral localization signal. J Virol. 2002Apr; 76(7): 3544–53. doi: 10.1128/JVI.76.7.3544-3553.200211884578
4. Taubenberger JK, Morens DM, The pathology of influenza virus infections. Annu Rev Pathol. 2008Aug; 3:499–522. doi: 10.1146/annurev.pathmechdis.3.121806.15431618039138
5. Ward HE, Nicholas TE, Alveolar type I and type II cells. Aust N Z J Med. 1984Oct; 14(5 Suppl 3): 731–734. 6598039
6. Sanders CJ, Vogel P, McClaren JL, Bajracharya R, Doherty PC, Thomas PG, Compromised respiratory function in lethal influenza infection is characterized by the depletion of type I alveolar epithelial cells beyond threshold levels. Am J Physiol Lung Cell Mol Physiol. 2013Apr1; 304 (7): L481–8. doi: 10.1152/ajplung.00343.201223355384
7. Brandes M, Klauschen F, Kuchen S, Germain RN, A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell. 2013Jul3; 154(1): 197–212. doi: 10.1016/j.cell.2013.06.01323827683
8. Korteweg C, Gu J, Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol. 2008May; 172(5): 1155–70. doi: 10.2353/ajpath.2008.07079118403604
9. Laidlaw BJ, Decman V, Ali MA, Abt MC, Wolf AI, Monticelli LA, Mozdzanowska K, Angelosanto JM, Artis D, Erikson J, Wherry EJ, Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity. PLoS Pathog. 2013Mar; 9(3): e1003207. doi: 10.1371/journal.ppat.100320723516357
10. Schneider C, Nobs SP, Heer AK, Kurrer M, Klinke G, van Rooijen N, Vogel J, Kopf M, Alveolar macrophages are essential for protection from respiratory failure and associated morbidity following influenza virus infection. PLoS Pathog. 2014Apr3; 10(4) e1004053. doi: 10.1371/journal.ppat.100405324699679
11. Kim HM, Lee YW, Lee KJ, Kim HS, Cho SW, van Rooijen N, Guan Y, Seo SH, Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs. J Virol. 2008May; 82(9): 4265–74. doi: 10.1128/JVI.02602-0718287245
12. Purnama C, Ng SL, Tetlak P, Setiagani YA, Kandasamy M, Baalasubramanian S, Karjalainen K, Ruedl C, Transient ablation of alveolar macrophages leads to massive pathology of influenza infection without affecting cellular adaptive immunity. Eur J Immunol. 2014Jul; 44(7): 2003–12. doi: 10.1002/eji.20134435924687623
13. Thepen T, Rooijen NV, Krall G, Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice J. Exp. Med. 1989Aug; 170: 499–509.
14. Jansen HM, The role of alveolar macrophages and dendritic cells in allergic airway sensitization. Allergy. 1996May; 51(5): 279–92. 8836331
15. Balhara J, Gounni AS, The alveolar macrophages in asthma: a double-edged sword. Mucosal Immunology2012Nov; 5(6): 605–9. doi: 10.1038/mi.2012.7422910216
16. Thepen T, Van Rooijen N, Kraal G, Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J Exp Med. 1989Aug1; 170(2): 499–509. 2526847
17. Barnes PJ, Alveolar macrophages in chronic obstructive pulmonary disease (COPD), Cell Mol Biol (Noisy-le-grand). 2004; 50.
18. Woodruff PG, Koth LL, Yang YH, Rodriguez MW, Favoreto S, Dolganov GM, Paquet AC, Erle DJ, A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med. 2005Dec1; 172(11): 1383–92. doi: 10.1164/rccm.200505-686OC16166618
19. Pribul PK, Harker J, Wang B, Wang H, Tregoning JS, Schwarze J, Openshaw PJ, Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development. J Virol. 2008May; 82(9): 4441–8. doi: 10.1128/JVI.02541-0718287232
20. Speck Nancy A., Gilliland D. Gary, Core-binding factors in haematopoiesis and leukaemia. Nature Reviews Cancer2002July (2): 502–513.
21. de Bruijn MF, Speck NA, Core-binding factors in hematopoiesis and immune function. Oncogene. 2004May (24): 4238–48. doi: 10.1038/sj.onc.120776315156179
22. Borregaard N, Theilgaard-Mönch K, Sørensen OE, Cowland JB, Regulation of human neutrophil granule protein expression. Curr Opin Hematol. 2001Jan; 8(1): 23–7. 11138622
23. Kirby AC, Raynes JG, Kaye PM, CD11b regulates recruitment of alveolar macrophages but not pulmonary dendritic cells after pneumococcal challenge. J Infect Dis. 2006Jan15; 193(2): 205–13. doi: 10.1086/49887416362884
24. Kopf M, Schneider C, Nobs S. P., The development and function of lung- resident macrophages and dendritic cells. Nature Immunology. 2015 (16), 36–44.
25. Tate MD, Brooks AG, Reading PC, The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice. Respir Res. 2008Aug1; 9:57. doi: 10.1186/1465-9921-9-5718671884
26. Hufford MM, Kim TS, Sun J, Braciale TJ, Antiviral CD8+ T cell effector activities in situ are regulated by target cell type. J Exp Med. 2011Jan17; 208(1): 167–80. doi: 10.1084/jem.2010185021187318
27. Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, Pulendran B, García-Sastre A, Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci U S A. 2010June22; 107(25): 11531–11536. doi: 10.1073/pnas.091499410720534532
28. Rosenberger CM, Podyminogin RL, Askovich PS, Navarro G, Kaiser SM, Sanders CJ, McClaren JL, Tam VC, Dash P, Noonan JG, Jones BG, Surman SL, Peschon JJ, Diercks AH, Hurwitz JL, Doherty PC, Thomas PG, Aderem A, Characterization of innate responses to influenza virus infection in a novel lung type I epithelial cell model. J Gen Virol. 2014Feb; 95(Pt 2): 350–62. doi: 10.1099/vir.0.058438-024243730
29. McElroy MC, Kasper M, The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair. Eur Respir J. 2004Oct; 24(4): 664–73. doi: 10.1183/09031936.04.0009600315459148
30. Yamamoto K, Ferrari JD, Cao Y, Ramirez MI, Jones MR, Quinton LJ, Mizgerd JP, Type I alveolar epithelial cells mount innate immune responses during pneumococcal pneumonia. J Immunol. 2012Sep1;189(5): 2450–9. doi: 10.4049/jimmunol.120063422844121
31. Chuquimia OD, Petursdottir DH, Rahman MJ, Hartl K, Singh M, Fernández C, The role of alveolar epithelial cells in initiating and shaping pulmonary immune responses: communication between innate and adaptive immune systems. PLoS One. 2012;7(2): e32125. doi: 10.1371/journal.pone.003212522393384
32. Kambayashi T, Laufer TM, Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?Nat Rev Immunol. 2014Nov;14(11):719–30. doi: 10.1038/nri375425324123
33. Debbabi H, Ghosh S, Kamath AB, Alt J, Demello DE, Dunsmore S, Behar SM, Primary type II alveolar epithelial cells present microbial antigens to antigen-specific CD4+ T cells. Am J Physiol Lung Cell Mol Physiol. 2005Aug; 289(2): L274–9. doi: 10.1152/ajplung.00004.200515833765
34. Stegemann-Koniszewski S, Jeron A, Gereke M, Geffers R, Kröger A, Gunzer M, Bruder D, Alveolar Type II Epithelial Cells Contribute to the Anti-Influenza A Virus Response in the Lung by Integrating Pathogen- and Microenvironment-Derived Signals. MBio. 2016May3; 7(3). pii: e00276–16. doi: 10.1128/mBio.00276-1627143386
35. Cho HC, Lai CY, Shao LE, Yu J, Identification of tumorigenic cells in Kras(G12D)-induced lung adenocarcinoma. Cancer Res. 2011Dec1; 71(23): 7250–8. doi: 10.1158/0008-5472.CAN-11-090322088965
36. Kumagai Y, Takeuchi O, Kato H, Kumar H, Matsui K, Morii E, Aozasa K, Kawai T, Akira S, Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity. 2007Aug; 27(2): 240–52. doi: 10.1016/j.immuni.2007.07.01317723216
37. Huang DW, Sherman BT, Lempicki RA, Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nature Protoc. 2009; 4(1): 44–57.
38. Huang DW, Sherman BT, Lempicki RA, Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009; 37(1): 1–13. doi: 10.1093/nar/gkn92319033363
39. Tam VC, Quehenberger O, Oshansky CM, Suen R, Armando AM, Treuting PM, Thomas PG, Dennis EA, Aderem A, Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation. Cell. 2013Jul3; 154(1): 213–27. doi: 10.1016/j.cell.2013.05.05223827684
40. Oguin TH, Sharma S, Stuart AD, Duan S, Scott SA, Jones CK, Daniels JS, Lindsley CW, Thomas PG, Brown HA, Phospholipase D facilitates efficient entry of influenza virus, allowing escape from innate immune inhibition. J Biol Chem. 2014Sep12; 289(37): 25405–17. doi: 10.1074/jbc.M114.55881725065577
41. König R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, Bhattacharyya S, Alamares JG, Tscherne DM, Ortigoza MB, Liang Y, Gao Q, Andrews SE, Bandyopadhyay S, De Jesus P, Tu BP, Pache L, Shih C, Orth A, Bonamy G, Miraglia L, Ideker T, García-Sastre A, Young JA, Palese P, Shaw ML, Chanda SK, Human host factors required for influenza virus replication. Nature. 2010Feb11; 463 (7282): 813–7. doi: 10.1038/nature0869920027183
42. Fujioka Y, Tsuda M, Nanbo A, Hattori T, Sasaki J, Sasaki T, Miyazaki T, Ohba Y, A Ca2+ Dependent signaling circuit regulates influenza A virus internalization and infection. Nature Communications. 2013Nov14; 4; 2763. doi: 10.1038/ncomms376324434940
43. Rådmark O, Samuelsson B, 5-Lipoxygenase: mechanisms of regulation. The Journal of Biological Chemistry. 2002Feb8; 277, 4374–4379.
44. Romano M, Catalano A, Nutini M, D'Urbano E, Crescenzi C, Claria J, Libner R, Davi G, Procopio A, 5-lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factor. FASEB J. 2001Nov; 15(13): 2326–36. doi: 10.1096/fj.01-0150com11689458
45. Cortese JF, Spannhake EW, Eisinger W, Potter JJ, Yang VW, The 5-lipoxygenase pathway in cultured human intestinal epithelial cells. Prostaglandins. 1995Mar; 49(3): 155–66. 7652184
46. Wright L, Tuder RM, Wang J, Cool CD, Lepley RA, Voelkel NF, 5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension. Am J Respir Crit Care Med. 1998Jan; 157(1): 219–29. doi: 10.1164/ajrccm.157.1.97040039445303
47. Manev H, Uz T, Sugaya K, Qu T, Putative role of neuronal 5-lipoxygenase in an aging brain. FASEB J. 2000Jul; 14(10): 1464–9. 10877840
48. Uhl J, Klan N, Rose M, Entian KD, Werz O, Steinhilber D, The 5-lipoxygenase promoter is regulated by DNA methylation. J Biol Chem. 2002Feb8; 277(6): 4374–9. doi: 10.1074/jbc.M10766520011706027
49. Zhang Z, Chen CQ, Manev H, DNA methylation as an epigenetic regulator of neural 5-lipoxygenase expression: evidence in human NT2 and NT2-N cells. J Neurochem. 2004Mar; 88(6): 1424–30. 15009643
50. Imbesi M, Dzitoyeva S, Ng LW, Manev H, 5-Lipoxygenase and epigenetic DNA methylation in aging cultures of cerebellar granule cells. Neuroscience. 2009Dec29; 164(4): 1531–7. doi: 10.1016/j.neuroscience.2009.09.03919778587
51. Tighe S, Held MA, Isolation of total RNA from transgenic mouse melanoma subsets using fluorescence-activated cell sorting. Methods Mol Biol. 2010; 632:27–44. doi: 10.1007/978-1-60761-663-4_220217569
52. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL, Pachter L, Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nature Protocols (2012); 7:562–578. doi: 10.1038/nprot.2012.01622383036